XBI - SPDR S&P Biotech - Stock Price & Dividends

The SPDR S&P Biotech ETF (XBI) is an exchange-traded fund (ETF) designed to track the performance of the S&P Biotechnology Select Industry Index. This index is a subset of the broader S&P Total Market Index (S&P TMI), focusing specifically on the biotechnology sector.

To achieve its investment objective, the fund uses a sampling strategy, which means it selects a representative sample of securities from the index. The ETF typically invests at least 80% of its total assets in these securities, aiming to replicate the performance of the underlying index.

By investing in the SPDR S&P Biotech ETF, you'll gain exposure to a diversified portfolio of biotechnology companies, which are involved in the research, development, and production of innovative medical treatments, diagnostics, and equipment. This can provide a unique opportunity to tap into the growth potential of the biotech industry, which is driven by advances in medical science and technology.

The fund is listed on the NYSE Arca exchange and is managed by State Street Global Advisors, a leading asset management firm. You can find more information about the fund on the State Street Global Advisors website at http://www.spdrs.com.

The SPDR S&P Biotech ETF is domiciled in the United States, which means it is subject to US regulations and tax laws. This can be an important consideration for investors who need to manage their tax exposure or comply with specific regulatory requirements.